;

CPhI Worldwide 2019

Start getting ready for 2020 with Teva api at CPhI Worldwide

[19-09-2019]

It's almost that time again – time to visit CPhI Worldwide and head to the Teva api booth for news on all the latest pipeline products, plus outstanding expert insights, advanced new services, and maybe even a tasty, refreshing shake. We're looking forward to seeing you there!

Simply the largest exhibition in the pharmaceutical industry, CPhI Worldwide is more than a trade fair – it's an entire world buzzing with services, solutions, and some 45,000 pharma professionals from all over the globe. It's also Teva api's natural habitat, so we are delighted to be attending CPhI Worldwide 2019 in Frankfurt, November 5-7 at hall 6, booth 60F31.

Consistently recognized among the most trusted API suppliers, Teva api has a lengthy track record of product quality, expertise, and sterling service dating back over 84 years. We serve more than 1,000 customers in over 70 countries, with the industry's broadest portfolio of almost 400 products, manufactured at 17 International sites.

As has become an annual tradition, Teva api will be using CPhI Worldwide as the ideal platform for showcasing its upcoming products, while also offering customers the opportunity to meet and collaborate with an impressive lineup of multidisciplinary experts. Simply drop by Booth 60F31 or arrange a meeting to make sure you stay in the loop.

 

special preview of the latest Teva api products

CPhI Worldwide is always a highlight on the industry calendar, and we are pleased to report that it will both cap a very successful year for Teva api and lead into what is sure to be a similarly productive 2020.

This year, we will be unveiling 10 new APIs for the following indications:

Baricitinib  – rheumatoid arthritis

Dalbavancin – antibiotic

Baloxavir Marboxil – flu

Larotrectinib – anticancer

Acalabrutinib – anticancer

Lorlatinib – anticancer

Letermovir – HCMV infection

Brexanolone – postpartum depression

Oritavancin – antibiotic

Siponimod – multiple sclerosis

All our APIs are developed and produced under exacting conditions at ultramodern plants worldwide, in strict compliance and cooperation with the FDA, EMA, as well as additional local authorities. Teva api, as a division of Teva Pharmaceuticals, was recently awarded an EcoVadis Silver Medal in recognition of our responsible conduct in environment, labor and human rights practices, ethics and sustainable procurement – putting us in the top 16% of all pharmaceutical companies. As ever, our dedicated API experts will be on hand to fill you in and answer your questions about any or all of our new products. Contact us here as soon as possible to schedule a meeting.

 

Meet Teva api's leadership

While many of you have already been in contact with our regional sales managers, CPhI offers the unmissable opportunity to meet Teva api's sales leadership face to face and discuss new opportunities for collaboration. Current and potential customers alike are invited to schedule a meeting with our highly experienced executives, who can provide unique insights on a variety of relevant issues. In attendance this year will be Mrs. Kerri McCullough Wood, SVP & Head of Commercial, as well as Mr. Uri Gat-Palash, Senior Director, Head of EU Sales, Ms. Moran Eshel, Product Management Director, Mr David Seignolle, VP TAPI Supply Chain Management, Nimrod Bar-Zvi Head of TAPI Sales in Americas and China, and also a team of expert account managers who will all be happy to introduce you to Teva api's broad portfolio of products and services. On the regulatory side, Dr. Tal Harel, our Global Regulatory Affairs Director, will be on hand to help you navigate complex regulatory issues, while Dr. Augusto Canavesi, Head of New Products Management, is just the person you need to address diverse R&D inquiries.  

"CPhI Worldwide highlights the very best of the pharmaceutical industry and is a fantastic opportunity for pharma professionals to discover everything Teva api has to offer. I'm looking forward to meeting customers old and new, and discussing a whole world of opportunities with them in Frankfurt."  – Kerri McCullough Wood, SVP & Head of Commercial

Our experts are sure to be in great demand, so please contact us here or reach out to your account manager to arrange a meeting in advance.

 

Advanced API sterilization service

Teva api recently added innovative aseptic sterilization services to its extensive portfolio, offering yet more convenience and top-notch quality to customers worldwide. Our brand new facility was launched at the end of 2018 and has already become a major factor for many customers when selecting their API supplier. Fully FDA approved, this state-of-the-art facility uses the aseptic filtration technique, which avoids damaging the API (essential for sensitive products) or forming new impurities. An on-site microbiological lab eliminates any possibility of contamination, and we also utilize dual packaging to ensure total sterility of the supplied API. For more details, please read our white paper or visit Booth 60F31 to get all the details from our R&D and regulatory experts.

 

Shake things up at the Teva api booth

Visiting CPhI is always a thrilling, informative experience, but we know from experience that a full day of meetings and presentations can quickly drain your energy. Thanks to Teva api's customer-centric approach, we'd like to invite you to Booth 60F31 for a tasty energy boost! Everyone who drops by our booth will be invited to enjoy a fresh, colorful fruit shake. As you know, we are all about high quality ingredients, and our shakes are no different! Our mini on-site "coffee shop" will also serve up a range of other hot and cold beverages, providing the perfect haven where you can relax, get organized, and prepare to tackle the next few hours of the event.

As you can see, Teva api's booth is the place to visit for an entire world of industry updates, pipeline information, expert insights, and more. We look forward to meeting and collaborating with you in Frankfurt – and also at CPhI Worldwide 2020 in gorgeous Milan, Italy.

About the author

Uri Gat-Palash is Senior Director, Head of Teva api Sales Europe. He has held several senior executive positions at Teva Pharmaceuticals, leading commercial and business development initiatives across Europe, as well as in Asia. Uri graduated with a BA and MBA from the Hebrew University of Jerusalem.